round button
Chat now

Mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e África – Tendências do setor e previsão para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e África – Tendências do setor e previsão para 2029

  • Medical Devices
  • Publish Reports
  • Mar 2022
  • MEA
  • 350 Páginas
  • Número de tabelas: 142
  • Número de figuras: 28

Mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África, por serviço (redação e submissões regulamentares, registo regulamentar e aplicações de ensaios clínicos, consultoria regulamentar, representação jurídica, serviços de gestão de dados, serviços de fabrico e controlos químicos (CMC) e outros), indicação ( Oncologia, Neurologia , Cardiologia, Química Clínica e Imunoensaios, Medicina de Precisão , Doenças Infecciosas, Diabetes, Testes Genéticos, VIH/SIDA, Hematologia, Testes de Drogas/Farmacogenómica, Transfusão de Sangue, Ponto de Atendimento e Outros ), Modelo de Implementação (Cloud e On -Instalações), Dimensão da Organização (Pequenas e Médias Empresas (PME) e Grandes Empresas), Estágio (Clínica, Pré-clínica e PMA (Autorização Pós-Comercialização)), Classe (Classe I , Classe II e Classe III), Utilizador Final (empresas farmacêuticas, empresas de dispositivos médicos, empresas de biotecnologia e outras), país (África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel, resto do Médio Oriente e África) Tendências e previsões da indústria para 2029.

Mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e África

Análise de Mercado e Insights  : Mercado de Outsourcing de Assuntos Regulamentares IVD no Médio Oriente e África

Espera-se que o mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África ganhe crescimento de mercado no período de previsão de 2022 a 2029. A Data Bridge Market Research analisa que o mercado está a crescer com o CAGR de 11,6% no período de previsão de 2022 a 2029 e prevê-se atingir os 47.861,92 milhares de dólares até 2029.

  • Os produtos de diagnóstico in vitro são reagentes, dispositivos e sistemas utilizados para diagnosticar doenças ou outras condições, incluindo a determinação do estado de saúde de uma pessoa para curar, mitigar, tratar ou prevenir doenças. Estes produtos destinam-se a ser utilizados na recolha, preparação e exame de amostras do corpo humano. Os assuntos regulamentares desempenham um papel crucial na indústria dos dispositivos de diagnóstico in vitro (IVD) e dos dispositivos médicos. A externalização de serviços de assuntos regulamentares envolve a redação médica e a publicação de documentação regulamentar por profissionais que contribuem para a produção de documentos de alta qualidade para projetos de investigação clínica. A procura de outsourcing de serviços regulamentares está a aumentar substancialmente nos estudos clínicos realizados em economias emergentes, proporcionando uma plataforma saudável para o crescimento desta indústria.

Os principais fatores que impulsionam o crescimento do mercado de externalização de assuntos regulamentares IVD são o aumento da prevalência de doenças crónicas em toda a região e o avanço tecnológico em diversos dispositivos de diagnóstico in vitro. O aumento da aquisição estratégica e da parceria entre organizações está a criar oportunidades para o crescimento do mercado. A mudança nas regulamentações relativas a dispositivos médicos em diferentes regiões está a funcionar como a principal restrição para o mercado de externalização de assuntos regulamentares de IVD. A falta de infraestruturas no serviço de saúde está a funcionar como um grande desafio para o crescimento do mercado.

Este relatório de mercado de outsourcing de assuntos regulamentares IVD fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado , aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e África

Médio Oriente e África IVD Assuntos Regulamentares Outsourcing Âmbito do mercado e dimensão do mercado

O mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África está segmentado em sete segmentos notáveis ​​que se baseiam nos serviços, indicação, modo de implementação, tamanho da organização, fase, classe e utilizador final.

  • Com base em serviços, o mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África está segmentado em redação e submissões regulamentares, registo regulamentar e aplicações de ensaios clínicos, consultoria regulamentar, representação jurídica, serviços de gestão de dados, serviços de fabrico e controlos químicos (CMC), e outros. Em 2022, espera-se que a redação e as submissões regulamentares dominem, uma vez que são económicas e as características flexíveis da solução da tecnologia de computação em nuvem na regulamentação IVD fornecem uma infraestrutura estável com produção máxima para as organizações que negoceiam sistemas IVD.
  • Com base na indicação, o mercado de outsourcing de assuntos regulamentares IVD do Médio Oriente e África está segmentado em oncologia, neurologia, cardiologia, química clínica e imunoensaios, medicina de precisão, doenças infeciosas, diabetes, testes genéticos, VIH/SIDA, hematologia , testes de drogas/ farmacogenómica, transfusão de sangue, ponto de atendimento e outros. Em 2022, prevê-se que o segmento oncológico domine, uma vez que ajuda a melhorar a previsibilidade do processo de desenvolvimento de medicamentos oncológicos e torna-se uma ferramenta importante para o oncologista na escolha do tratamento para o doente
  • Com base no modo de implementação, o mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África está segmentado em nuvem e local. Em 2022, espera-se que o segmento da cloud domine, uma vez que é a solução que apresenta características flexíveis da tecnologia de computação em cloud, é económica na regulamentação de IVD e fornece uma infraestrutura estável com produção máxima para as organizações que negoceiam sistemas de IVD .
  • Com base no tamanho da organização, o mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África está segmentado em pequenas e médias empresas (SMES) e grandes empresas. Em 2022, prevê-se que o segmento das grandes empresas domine à medida que aumenta a aquisição estratégica e a parceria entre organizações.
  • Com base no estágio, o mercado de externalização de assuntos regulamentares de IVD no Médio Oriente e em África está segmentado em clínico, pré-clínico e PMA (autorização pós-comercialização). Em 2022, prevê-se que o segmento clínico domine o mercado com o surgimento de diversos serviços e padrões tecnológicos eficientes.
  • Com base na classe, o mercado de externalização de assuntos regulamentares IVD no Médio Oriente e em África está segmentado em classe I, classe II e classe III. Em 2022, espera-se que o segmento de classe I domine o mercado, uma vez que não envolve risco para a saúde pública ou baixo risco pessoal com regulamentações mais baixas. Estes são muito procurados e 47% dos dispositivos médicos enquadram-se nesta categoria.
  • Com base no utilizador final, o mercado de externalização de assuntos regulamentares de IVD no Médio Oriente e em África está segmentado em empresas farmacêuticas, empresas de dispositivos médicos, empresas de biotecnologia, entre outras. Em 2022, prevê-se que as empresas de dispositivos médicos dominem o mercado. O aumento das despesas com cuidados de saúde resultou ainda numa melhor oferta de oportunidades de investigação e desenvolvimento.

Análise a nível de país do mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África

O mercado de outsourcing de assuntos regulamentares IVD no Médio Oriente e em África é analisado e são fornecidas informações sobre o tamanho do mercado por país, serviços, indicação, modo de implantação, tamanho da organização, fase, classe e utilizador final.

Os países abrangidos pelo relatório de mercado de externalização de assuntos regulamentares IVD do Médio Oriente e África são a África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel, Resto do Médio Oriente e África.

A África do Sul está a dominar o mercado na região do Médio Oriente e África devido aos desenvolvimentos no sector da saúde e ao avanço tecnológico nas actividades de I&D das empresas em toda a região.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado nacional que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.

Procura crescente de terceirização de assuntos regulamentares de IVD

O mercado de externalização de assuntos regulamentares IVD no Médio Oriente e África também fornece análises de mercado detalhadas para o crescimento da indústria de cada país com vendas, vendas de componentes, impacto do desenvolvimento tecnológico na externalização de assuntos regulamentares IVD e mudanças nos cenários regulamentares com o seu suporte para os assuntos regulamentares IVD. Os dados estão disponíveis para o período histórico de 2012 a 2020.

Cenário competitivo e análise de quota de mercado de outsourcing de assuntos regulamentares de IVD no Médio Oriente e África

O panorama competitivo do mercado de externalização de assuntos regulamentares de IVD no Médio Oriente e em África fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos , pipelines de testes de produtos, aprovações de produtos, patentes, largura e amplitude do produto, domínio da aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de externalização de assuntos regulamentares de IVD no Médio Oriente e em África.

Alguns dos principais players que operam no relatório são o mercado de outsourcing de assuntos regulamentares IVD são a Freyr Solutions, a PPD Inc. (uma subsidiária da Thremofisher Scientific Inc.), a EMERGO, a ICON, a Parexel International Corporation, a CRITERIUM, INC., a Groupe ProductLife SA , Labcorp Drug Development, WuXi AppTec, Genpact, Medpace, Dor Pharmaceutical Services, Qserve, entre outros. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

Muitos desenvolvimentos de produtos são também iniciados por empresas de todo o mundo que também estão a acelerar o crescimento do mercado de externalização de assuntos regulamentares de IVD no Médio Oriente e em África.

Por exemplo,

  • Em novembro de 2021, a USA-9 Technology Magazine listou a Freyr entre os “10 melhores fornecedores de soluções tecnológicas de 2021. A USA-9.com é uma revista de tecnologia que listou a Freyr Solutions, uma solução reguladora líder global e fornecedora de serviços, como o “ Os 10 melhores fornecedores de soluções tecnológicas de 2021, à medida que a Fryer continua a conceber soluções de software inovadoras e a apoiar os clientes nos seus respetivos objetivos de conformidade. Isto ajudou a empresa a aumentar a sua popularidade.
  • Em dezembro de 2021, a Labcorp Drug Development adquiriu a Toxikon Corporation, que é uma organização de investigação por contrato que oferece o melhor serviço de ensaios não clínicos da sua categoria. A adição da Toxikon à Labcorp Drug Development reforçou o forte portefólio de desenvolvimento não clínico da Labcorp e criou uma pegada estratégica para a empresa estabelecer parcerias com clientes farmacêuticos e de biotecnologia na área de Boston, Massachusetts. Isso ajudou a empresa a expandir o seu negócio.

As parcerias, joint ventures e outras estratégias aumentam a quota de mercado da empresa com maior cobertura e presença. Também oferece o benefício para a organização melhorar a sua oferta de outsourcing de assuntos regulamentares de IVD através de uma gama alargada de tamanhos.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 SERVICE TIMELINE CURVE

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, REGULATORY SCENARIO

4.1.1 THE U.S.

4.1.2 REGULATIONS IN EUROPE

4.1.3 REGULATIONS IN ASIA

4.1.3.1 CHINA

4.1.3.2 SOUTH KOREA

4.1.3.3 MALAYSIA

4.1.3.4 THAILAND

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES ACROSS THE REGION

5.1.2 TECHNOLOGICAL ADVANCEMENT IN DEVELOPING VARIOUS IN VITRO DIAGNOSTIC DEVICES

5.1.3 DEVELOPMENT OF PROJECT-BASED SUPPORT LEADS TO LONG TERM OUTSOURCING AGREEMENT AMONG ORGANIZATION

5.1.4 INCREASE IN PRODUCT REGISTRATION NUMBERS AND CLINICAL TRIAL APPROVALS ACROSS THE REGION

5.2 RESTRAINTS

5.2.1 STRINGENT REGULATIONS REGARDING MEDICAL DEVICES IN DIFFERENT REGIONS

5.2.2 HIGHER COST RELATED TO MAINTENANCE AND OUTSOURCING OF IVD

5.3 OPPORTUNITIES

5.3.1 RISE IN STRATEGIC ACQUISITION & PARTNERSHIP AMONG ORGANIZATION

5.3.2 EMERGENCE OF VARIOUS EFFICIENT TECHNOLOGICAL SERVICES AND STANDARDS

5.3.3 INCREASE IN R&D ACTIVITIES BY COMPANIES ACROSS THE REGION

5.4 CHALLENGES

5.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE

5.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING IN VITRO DIAGNOSTIC DEVICES

6 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE

6.1 OVERVIEW

6.2 REGULATORY WRITING & SUBMISSIONS

6.3 LEGAL REPRESENTATION

6.4 REGULATORY CONSULTING

6.5 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

6.6 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

6.7 DATA MANAGEMENT SERVICES

6.8 OTHERS

7 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION

7.1 OVERVIEW

7.2 CLINICAL CHEMISTRY AND IMMUNOASSAYS

7.3 INFECTIOUS DISEASES

7.3.1 VIROLOGY

7.3.2 MICROBIOLOGY AND MYCOLOGY

7.3.3 BACTERIOLOGY

7.3.4 SEPSIS

7.3.5 HEPATITIS B

7.3.6 HEPATITIS C

7.3.7 MALARIA

7.3.8 TUBERCULOSIS

7.3.9 SYPHILIS

7.3.10 HUMAN PAPILLOMAVIRUS (HPV) INFECTION

7.3.11 OTHERS

7.4 HAEMATOLOGY

7.5 DRUG TESTING/PHARMACOGENOMICS

7.6 PRECISION MEDICINE

7.7 DIABETES

7.8 BLOOD TRANSFUSION

7.9 CARDIOLOGY

7.1 POINT OF CARE

7.10.1 WAIVED TEST

7.10.2 AT HOME TESTS

7.11 ONCOLOGY

7.12 NEUROLOGY

7.13 HIV/AIDS

7.14 GENETIC TESTING

7.15 OTHERS

8 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS

8.1 OVERVIEW

8.2 CLASS I

8.3 CLASS III

8.4 CLASS II

9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE

9.1 OVERVIEW

9.2 CLOUD

9.3 ON-PREMISES

10 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE

10.1 OVERVIEW

10.2 LARGE ENTERPRISES

10.3 SMALL & MEDIUM ENTERPRISES (SMES)

11 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE

11.1 OVERVIEW

11.2 CLINICAL

11.3 PRECLINICAL

11.4 PMA (POST MARKET AUTHORIZATION)

12 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER

12.1 OVERVIEW

12.2 MEDICAL DEVICE COMPANIES

12.2.1 BY ORGANIZATION SIZE

12.2.1.1 LARGE ENTERPRISES

12.2.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.2.2 BY SERVICE

12.2.2.1 REGULATORY WRITING & SUBMISSIONS

12.2.2.2 LEGAL REPRESENTATION

12.2.2.3 REGULATORY CONSULTING

12.2.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.2.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.2.2.6 DATA MANAGEMENT SERVICES

12.2.2.7 OTHERS

12.3 PHARMACEUTICAL COMPANIES

12.3.1 BY ORGANIZATION SIZE

12.3.1.1 LARGE ENTERPRISES

12.3.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.3.2 BY SERVICE

12.3.2.1 REGULATORY WRITING & SUBMISSIONS

12.3.2.2 LEGAL REPRESENTATION

12.3.2.3 REGULATORY CONSULTING

12.3.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.3.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.3.2.6 DATA MANAGEMENT SERVICES

12.3.2.7 OTHERS

12.4 BIOTECHNOLOGY COMPANIES

12.4.1 BY ORGANIZATION SIZE

12.4.1.1 LARGE ENTERPRISES

12.4.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.4.2 BY SERVICE

12.4.2.1 REGULATORY WRITING & SUBMISSIONS

12.4.2.2 LEGAL REPRESENTATION

12.4.2.3 REGULATORY CONSULTING

12.4.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.4.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.4.2.6 DATA MANAGEMENT SERVICES

12.4.2.7 OTHERS

12.5 OTHERS

13 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION

13.1 MIDDLE EAST & AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 U.A.E

13.1.4 EGYPT

13.1.5 ISRAEL

13.1.6 REST OF MIDDLE EAST & AFRICA

14 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ICON PLC

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 MEDPACE

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 PAREXEL INTERNATIONAL CORPORATION

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 LABCORP DRUG DEVELOPMENT

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 PPD INC. (A SUBSIDIARY OF THERMOFISHER SCIENTIFIC INC.)

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENTS

16.6 CHARLES RIVER LABORATORIES

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENTS

16.7 FREYR

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ASSENT COMPLIANCE INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 ANDAMAN MEDICAL

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 ASIA ACTUAL

16.10.1 COMPANY SNAPSHOT

16.10.2 SERVICE PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 AXSOURCE

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 CRITERIUM, INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 DOR PHARMACEUTICAL SERVICES

16.13.1 COMPANY SNAPSHOT

16.13.2 SERVICE PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 EMERGO BY UL

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 GENPACT

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 GROUPE PRODUCTLIFE S.A.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 LORENZ LIFE SCIENCES GROUP

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 MAKROCARE

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 MARACA INTERNATIONAL BVBA

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 MDICONSULTANTS, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 PBC BIOMED

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 PROMEDICA INTERNATIONAL, A CALIFORNIA CORPORATION

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 PROPHARMA GROUP

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 QSERVE

16.24.1 COMPANY SNAPSHOT

16.24.2 SERVICE PORTFOLIO

16.24.3 RECENT DEVELOPMENTS

16.25 REGULATORY COMPLIANCE ASSOCIATES INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENT

16.26 RMQ+

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENT

16.27 SARACA SOLUTIONS PRIVATE LIMITED

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENT

16.28 VCLS

16.28.1 COMPANY SNAPSHOT

16.28.2 PRODUCT PORTFOLIO

16.28.3 RECENT DEVELOPMENTS

16.29 WUXI APPTEC

16.29.1 COMPANY SNAPSHOT

16.29.2 REVENUE ANALYSIS

16.29.3 PRODUCT PORTFOLIO

16.29.4 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Lista de Tabela

TABLE 1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 2 MIDDLE EAST & AFRICA REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 3 MIDDLE EAST & AFRICA LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 4 MIDDLE EAST & AFRICA REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 5 MIDDLE EAST & AFRICA REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 6 MIDDLE EAST & AFRICA CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 7 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND)

TABLE 8 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 10 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 11 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND)

TABLE 12 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 13 MIDDLE EAST & AFRICA HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 14 MIDDLE EAST & AFRICA DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 15 MIDDLE EAST & AFRICA PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 16 MIDDLE EAST & AFRICA DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 17 MIDDLE EAST & AFRICA BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 18 MIDDLE EAST & AFRICA CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 19 MIDDLE EAST & AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 20 MIDDLE EAST & AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 21 MIDDLE EAST & AFRICA ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 22 MIDDLE EAST & AFRICA NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 23 MIDDLE EAST & AFRICA HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 24 MIDDLE EAST & AFRICA GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 25 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 26 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 27 MIDDLE EAST & AFRICA CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 28 MIDDLE EAST & AFRICA CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 29 MIDDLE EAST & AFRICA CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 30 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 31 MIDDLE EAST & AFRICA CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 32 MIDDLE EAST & AFRICA ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 33 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 34 MIDDLE EAST & AFRICA LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 35 MIDDLE EAST & AFRICA SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 36 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 37 MIDDLE EAST & AFRICA CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 38 MIDDLE EAST & AFRICA PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 39 MIDDLE EAST & AFRICA PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 40 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 41 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 42 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 43 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 44 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 45 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 46 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 47 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 48 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 49 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 50 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 52 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 53 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 54 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 55 MIDDLE EAST AND AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 56 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 57 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 58 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 59 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 60 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 61 MIDDLE EAST AND AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 62 MIDDLE EAST AND AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 65 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 66 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 67 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 68 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 69 SOUTH AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 70 SOUTH AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 71 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 72 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 73 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 74 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 75 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 76 SOUTH AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 77 SOUTH AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 78 SOUTH AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 79 SOUTH AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 80 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 81 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 82 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 83 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 84 SAUDI ARABIA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 85 SAUDI ARABIA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 86 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 87 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 88 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 89 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 90 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 91 SAUDI ARABIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 92 SAUDI ARABIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 93 SAUDI ARABIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 94 SAUDI ARABIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 95 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 96 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 97 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 98 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 99 U.A.E INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 100 U.A.E POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 101 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 102 U.A.E. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 103 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 104 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 105 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 106 U.A.E MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 107 U.A.E MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 108 U.A.E PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 109 U.A.E PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 110 U.A.E BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 111 U.A.E BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 112 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 113 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 114 EGYPT INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 115 EGYPT POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 116 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 117 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 118 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 119 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 120 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 121 EGYPT MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 122 EGYPT MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 123 EGYPT PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 124 EGYPT PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 125 EGYPT BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 126 EGYPT BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 127 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 128 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 129 ISRAEL INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 130 ISRAEL POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 131 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 132 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 133 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 134 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 135 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 136 ISRAEL MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 137 ISRAEL MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 138 ISRAEL PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 139 ISRAEL PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 140 ISRAEL BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 141 ISRAEL BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 142 REST OF MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

Lista de Figura

FIGURE 1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029

FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017)

FIGURE 16 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021

FIGURE 17 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021

FIGURE 18 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021

FIGURE 19 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021

FIGURE 20 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021

FIGURE 21 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021

FIGURE 22 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021

FIGURE 23 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021)

FIGURE 24 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021)

FIGURE 25 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029)

FIGURE 26 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029)

FIGURE 27 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029)

FIGURE 28 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The Middle East and Africa IVD Regulatory Affairs Outsourcing Market will be projected to grow at a CAGR of 11.6% during the forecast period of 2022 to 2029.
The Middle East and Africa IVD Regulatory Affairs Outsourcing Market will be projected USD 47,861.92 thousand during the forecast period of 2022 to 2029.
The major players operating in the report are IVD regulatory affairs outsourcing market are Freyr Solutions, PPD Inc. (A Subsidiary of Thremofisher Scientific Inc.), EMERGO, ICON, Parexel International Corporation, CRITERIUM, INC., Groupe ProductLife S.A., Labcorp Drug Development, WuXi AppTec, Genpact, Medpace, Dor Pharmaceutical Services, Qserve, among others.
The major factors driving the growth of the IVD regulatory affairs outsourcing market are the rise in the prevalence of chronic diseases across the region and technological advancement in various in vitro diagnostic devices.
a